関連する実験動画
Updated: Jan 18, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
ラマダン中の糖尿病管理に関する知識の向上
A A Arie Widyastuti1, Nurul H Muchtar2, Jerry Nasarudin1
1Internal Medicine Department, Fatmawati General Hospital, Jl. RS. Fatmawati Raya, Cilandak Bar., Kec. Cilandak, Kota Jakarta Selatan, Daerah Khusus Ibukota, Jakarta, Indonesia.
Journal of Taibah University Medical Sciences
|January 16, 2026
まとめ
ラマダン中の断食は2型糖尿病患者にリスクをもたらします。ターゲットを絞った教育プログラムは、ラマダン中の安全な断食の実践と糖尿病管理に関する知識を大幅に向上させました。
科学分野:
- 内分泌学;公衆衛生;医学教育
背景:
- ラマダン中の断食は、2型糖尿病(T2DM)患者にとって健康上の課題をもたらします。;ラマダン中の安全な糖尿病管理を理解することは、T2DM患者にとって不可欠です。;既存の知識不足は、低血糖や高血糖などの深刻な健康合併症につながる可能性があります。
研究 の 目的:
- T2DM患者のラマダン断食に関する基礎知識を評価すること。;ラマダン中のT2DM管理に関するターゲットを絞った教育プログラムの効果を評価すること。;安全なラマダン遵守のための患者教育における具体的な改善点を特定すること。
主な方法:
- 単群、介入前/介入後テストの研究デザインが採用されました。;T2DMを有する116人のイスラム教徒患者が、ラマダンに焦点を当てた教育セッションに参加しました。;介入前と介入後に24項目の質問票を使用して知識を評価し、データは適切な統計テストを使用して分析されました。
主要な成果:
- 介入後の全体的な知識スコアは、介入前は50.9%であったものが90.5%に有意に増加しました(p=0.001)。;断食のリスク、食事の原則、身体活動、投薬のリスク、リスク層別化の理解において顕著な改善が見られました。;適切な血糖モニタリング頻度に関する知識は、わずかな改善しか示しませんでした。
結論:
- 構造化されたラマダンに焦点を当てた教育プログラムは、T2DM患者の安全な断食のための知識を効果的に向上させます。;将来の介入では、食事戦略、スルホニル尿素のリスク、標準化された血糖モニタリングを強調する必要があります。;患者教育の最適化は、T2DMを有する個人のラマダン中の健康転帰を改善するための鍵となります。
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Hypoglycemia and Glucagon
838
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
838
Insulin: Dosing Regimen and Adverse Effects
689
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
689

